Previous Infection with SARS-CoV-2 Correlates with Increased Protective Humoral Responses after a Single Dose of an Inactivated COVID-19 VaccineSARS-CoV-2에 대한 이전 감염은 비활성화된 COVID-19 백신의 1회 투여 후 증가된 보호 체액 반응과 관련이 있습니다Article Published on 2022-03-022022-09-11 Journal: Viruses [Category] SARS, 변종, 치료기술, [키워드] anti-SARS-CoV-2 antibodies anti-SARS-CoV-2 antibody anti-SARS-CoV-2 humoral antibodies antibody antibody kinetics antibody levels Antibody Response Antibody responses assays both viruses CoronaVac COVID-19 COVID-19 vaccine detectable dose elicited ELISA evaluate FIVE Gamma had no immunization inactivated Inactivated vaccine increase in Increased indicated individual induce Lineage lineage B.1 naïve individuals Neutralizing activity neutralizing assays plaque Previous studies previous study PRNT Protective antibody protective antibody response protective antibody responses response retained SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 vaccine second dose sera specific antibodies subject vaccinated individual vaccinated individuals vaccination vaccine dose vaccinees variant were measured [DOI] 10.3390/v14030510 PMC 바로가기 [Article Type] Article
Recall response to COVID-19 antigen is preserved in people with multiple sclerosis on anti-CD20 medications – A pilot study항-CD20 약물에 대한 다발성 경화증 환자에서 COVID-19 항원에 대한 회상 반응이 보존됨 - 파일럿 연구Article Published on 2022-03-012022-09-12 Journal: Multiple sclerosis and related disorders [Category] Coronavirus, MERS, SARS, 진단, [키워드] anti-CD20 anti-CD20 therapy antibody antibody levels antibody production Antibody Response Antibody titers Antigen B cell B cell depletion booster booster dose booster vaccination Booster vaccine both group Cell Cohort cohorts condition COVID-19 elicited enrolled evaluated humoral immunization implication individual management mean difference medication medications multiple sclerosis no correlation Patient peripheral circulation pilot study preserved proportion recall respond SARS-CoV-2 SARS-CoV-2 antibody SARS-CoV-2 vaccination significantly higher Therapies vaccination [DOI] 10.1016/j.msard.2022.103560 PMC 바로가기 [Article Type] Article
Antibody responses to SARS-CoV-2 nucleocapsid and spike proteins in hospitalized patients with COVID-19: A multicenter, retrospective, cross-sectional study in Japan코로나19로 입원한 환자의 SARS-CoV-2 뉴클레오캡시드 및 스파이크 단백질에 대한 항체 반응: 일본의 다기관, 후향적, 횡단면 연구Multicenter Study Published on 2022-03-012022-09-11 Journal: Respiratory investigation [Category] MERS, SARS, 진단, 치료기술, 치료법, [키워드] amplification Anti-spike anti-spike protein IgG antibody antibody levels Antibody Response Antibody responses automated collected coronavirus disease Coronavirus disease 2019 COVID-19 cross-sectional detect Diagnosis early-stage COVID-19 examined gene amplification healthcare worker hospitalized patient IgG IgM IgM antibodies immune immune responses Immunoglobulin Japan multicenter negative controls peaked plateau Protein retrospective SARS-CoV-2 SARS-CoV-2 nucleocapsid sera Seroconversion Serological assay serological test serology Seropositivity serum sample serum samples significant difference specificity Spike protein statistically significant symptom onset total Ig Validity were used [DOI] 10.1016/j.resinv.2021.11.006 PMC 바로가기 [Article Type] Multicenter Study
Evaluation of antibody response after COVID-19 vaccination of healthcare workers의료진의 코로나19 예방접종 후 항체반응 평가Article Published on 2022-03-012022-09-11 Journal: Journal of medical virology [Category] MERS, SARS, 진단, 치료법, [키워드] addition age antibody antibody levels Antibody Response antibody response against Antibody titer Antibody titers BMI BMI values body mass body mass index CoronaVac COVID-19 COVID-19 vaccination develop dose effective Elecsy Elecsys evaluated examined Factor female Gender HCW healthcare healthcare worker Healthcare workers immune response Immunity Inactivated vaccine individuals infected with COVID-19 interquartile range IQR male median age nucleocapsid protein obese participant Participants participated postvaccination RBD RBD protein Receptor binding Receptor binding domain Receptor-binding domain SARS-CoV-2 SARS-CoV-2 spike protein second dose second dose of vaccine Seropositivity Smokers smoking Spike protein the receptor-binding domain the SARS-CoV-2 U/mL Vaccine Volunteer volunteers was determined was measured [DOI] 10.1002/jmv.27420 PMC 바로가기 [Article Type] Article
Low-entry-barrier point-of-care testing of anti-SARS-CoV-2 IgG in the population of Upper Austria from December 2020 until April 2021—a feasible surveillance strategy for post-pandemic monitoring?2020 년 12 월부터 2021 년 4 월까지 오스트리아 어퍼 오스트리아 인구에서 항 -SARS-COV-2 IGG의 저지전 배리어 요약 테스트-밴혈 후 모니터링을위한 실행 가능한 감시 전략?Research Paper Published on 2022-02-282022-09-08 Journal: Analytical and bioanalytical chemistry [Category] COVID19(2023년), Fulltext, MERS, SARS, 진단, 치료기술, [키워드] Abstract acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 analyses Analysis analyzed anonymized data anti-SARS-CoV-2 IgG antibody antibody levels Antigen approach continuous monitoring coronavirus COVID-19 COVID-19 pandemic defined diagnostic diagnostic testing estimate feasible IgG antibodies IgG antibody immune Immune status Immunoglobulin Immunoglobulin G Infection International limit Local National PCR Peripheral blood Pharmacy point-of-care Population populations Prevalence Rapid test Region reported respiratory SARS-CoV-2 SARS-CoV-2 antigen SARS-CoV-2 antigens Seroprevalence severe acute respiratory syndrome Coronavirus Spread Surveillance upper vaccinated individuals Volunteer volunteers [DOI] 10.1007/s00216-022-03966-z PMC 바로가기 [Article Type] Research Paper
Innovative FO-SPR Label-free Strategy for Detecting Anti-RBD Antibodies in COVID-19 Patient Serum and Whole BloodCOVID-19 환자 혈청 및 전혈에서 항-RBD 항체 검출을 위한 혁신적인 FO-SPR 무표지 전략Article Published on 2022-02-252022-09-11 Journal: ACS Sensors [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, [키워드] antibodies antibody antibody levels antibody response against Antigen approach aspect binding binding kinetics bioassay Blood Complete correlation COVID-19 COVID-19 pandemic COVID-19 patient serum COVID-19 patients COVID-19 severity diagnostic ELISA Evidence fiber FO-SPR His6-tagged RBD Hypothesis Immune status kinetic Patient polyclonal polyclonal antibody quantification RBD Receptor binding domain SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 spike protein serological serological test Serological tests serum significantly shorter Spike protein Strategy Support surface plasmon surface plasmon resonance Taking Viral viral infection Whole blood [DOI] 10.1021/acssensors.1c02215 PMC 바로가기 [Article Type] Article
The Comparability of Anti-Spike SARS-CoV-2 Antibody Tests is Time-Dependent: a Prospective Observational StudyAnti-Spike SARS-CoV-2 항체 검사의 비교 가능성은 시간에 따라 달라집니다: 전향적 관찰 연구Observational Study Published on 2022-02-232022-09-12 Journal: Microbiology Spectrum [Category] COVID19(2023년), MERS, SARS, 임상, 진단, [키워드] Abbott agreement antibody Antibody assays antibody levels Antibody test antibody tests AZD1222 binding antibody Blood blood collection booster changed clinical setting clinical settings clinician comparability correlation dependent on evaluated first dose greater homologous Initially International international standard Neutralization assay observational study participant Prospective prospective observational study provided quantified Quantitative Roche SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 antibody SARS-CoV-2 antibody test SARS-CoV-2 antibody tests second dose serology significantly Standardization Test the timing time-dependency vaccination Withdrawal [DOI] 10.1128/spectrum.01402-21 PMC 바로가기 [Article Type] Observational Study
Immunogenicity of BNT162b2, BBIBP-CorV and Gam-COVID-Vac vaccines and immunity after natural SARS-CoV-2 infection—A comparative study from Novi Sad, SerbiaBNT162b2, BBIBP-CorV 및 Gam-COVID-Vac 백신의 면역원성과 자연 SARS-CoV-2 감염 후 면역 - 세르비아 Novi Sad의 비교 연구Comparative Study Published on 2022-02-022022-09-12 Journal: PLoS ONE [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] age analyzed anti-S antibody antibody antibody levels BBIBP-CorV BNT162b2 challenge convalescent COVID-19 COVID-19 pandemic COVID-19 vaccine cross-sectional cross-sectional study DiaSorin followed by Gam-COVID-Vac Gam-COVID-Vac vaccine group IgG immune response Immunity immunogenicity individual investigated Italy Kruskal–Wallis test less LIAISON LIAISON SARS-CoV-2 S1/S2 IgG assay majority mass vaccination mean value no statistically significant difference Novi Sad of BNT162b2 Participants percentage Result robust S1/S2 SARS-CoV-2 second dose second dose of vaccine sera seroconversion rate seroconversion rates seroconverted seropositive serum Significant significant differences significantly higher statistically significant difference Vaccine vaccine dose Vaccines was collected was measured was used Wilcoxon rank-sum [DOI] 10.1371/journal.pone.0263468 PMC 바로가기 [Article Type] Comparative Study
SARS-CoV-2 Antibody Response After a Third Dose of the BNT162b2 Vaccine in Patients Receiving Maintenance Hemodialysis or Peritoneal DialysisObservational Study Published on 2022-02-012022-10-05 Journal: American journal of kidney diseases : the official [Category] COVID19(2023년), SARS, 임상, [키워드] acute respiratory syndrome Adverse adverse effects anti-SARS-CoV-2 Anti-spike anti-spike antibody anti-spike serology antibody antibody levels Antibody titer BNT162b2 BNT162b2 vaccine booster booster dose characterized Clinical outcome coronavirus coronavirus disease Coronavirus disease 2019 (COVID-19) dialysis dose End-stage renal disease End-stage renal disease (ESRD) evaluated event French General population greater Hemodialysis humoral Humoral response immune immune response Immunoglobulin increase in initial IQR maintenance median median age men observational study Patient patients treated Peritoneal dialysis plasma produced rationale receiving recent relationship Responder response SARS-CoV-2 second dose setting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) single center small sample size Spike protein Third booster dose treated vaccination Vaccine vaccine adverse effects. vaccine dose [DOI] 10.1053/j.ajkd.2021.08.005 PMC 바로가기 [Article Type] Observational Study
Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance – VISION Network, 10 States, August 2021-January 2022델타 및 오미크론 변이가 우세한 기간 동안 성인의 COVID-19 관련 응급실 및 긴급 치료 만남 및 입원에 대한 3차 mRNA 백신 접종의 효과 - VISION Network, 10개 주, 2021년 8월-2022년 1월Article Published on 2022-01-212022-09-11 Journal: Morbidity and Mortality Weekly Report [Category] 변종, [키워드] Against antibody levels B.1.1.529 B.1.617.2 BNT162b2 booster Care CDC clinics Combination COVID-19 COVID-19 vaccination COVID-19 vaccinations COVID-19 vaccine declined Delta delta variant Department dose Effectiveness eligible Emergency encounter estimate examined Factors highest hospital Hospitalization hospitalizations immune evasion Immunity immunocompromised individual immunocompromised individuals increase Infection interval laboratory-confirmed mRNA mRNA vaccine mRNA vaccines network neutralizing antibody of BNT162b2 omicron Omicron variant Period Pfizer Pfizer-BioNTech predominant receipt receive SARS-CoV-2 variant SARS-CoV-2 variants sequenced shown stratified the SARS-CoV-2 the United State The United States United States vaccination Vaccinations Vaccine variant viruses with COVID-19 [DOI] 10.15585/mmwr.mm7104e3 PMC 바로가기 [Article Type] Article